Latest Period
Q1 2026
Security Snapshot
Pacira BioSciences, Inc. - Common Stock (PCRX) Institutional Ownership
CUSIP: 695127100
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
240
Shares (Excl. Options)
43,579,743
Price
$22.60
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- PCRX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 43,579,743
- Total 13F value
- $985,375,457
- Portfolio coverage rank
- 0%
- Share change
- -3,095,566
- Value change
- -$75,505,778
- Number of holders
- 240
- Shares outstanding
- 40,532,351
- SEC-reported price per share
- $25.37
- Insider filing price
- $25.37
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PCRX - Pacira BioSciences, Inc. - Common Stock is tracked under CUSIP 695127100.
- 240 institutions reported positions in Q1 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 240 to 8 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $985,375,457 to $10,230,833.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 240 institutions filings for Q1 2026.
Security key
695127100
Latest holder period
Q1 2026
13F holders
240
13D/G owners
8
CIK / CUSIP context first
Open Q1 2026 holders
PCRX full holder history
Pacira BioSciences, Inc. SEC filings
Pacira BioSciences, Inc. company facts
Pacira BioSciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 695127100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
PCRX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | $189,462,213 | 7,017,119 | BlackRock, Inc. | 31 Mar 2025 | |||
| Doma Perpetual Capital Management LLC | 7.3% | +6.7% | $62,994,231 | 2,936,794 | 0% | Pedro Escudero | 11 Mar 2026 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.4% | $58,442,786 | 2,585,964 | Vanguard Portfolio Management | 31 Mar 2026 | |||
| RENAISSANCE TECHNOLOGIES LLC | 5% | -7.2% | $55,101,440 | -$6,633,198 | 2,138,201 | -11% | Renaissance Technologies LLC | 01 Jul 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.2% | $47,195,377 | 2,088,291 | Vanguard Capital Management | 31 Mar 2026 | |||
| DIMENSIONAL FUND ADVISORS LP | 5.1% | $46,570,110 | 2,060,597 | Dimensional Fund Advisors LP | 31 Mar 2026 | |||
| Pacer Advisors, Inc. | 1.3% | -81% | $16,245,036 | -$71,851,563 | 601,668 | -82% | Pacer Advisors, Inc. | 31 Mar 2025 |
| MILLENNIUM MANAGEMENT LLC | 0.7% | -88% | $9,331,875 | -$53,804,088 | 345,625 | -85% | Millennium Management LLC | 31 Mar 2025 |
As of 31 Mar 2026, 240 institutional investors reported holding 43,579,743 shares of Pacira BioSciences, Inc. - Common Stock (PCRX). This represents 108% of the company’s total 40,532,351 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
83%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 17% | 6,735,343 | -4.7% | 0% | $152,218,750 |
| Doma Perpetual Capital Management LLC | 6.9% | 2,777,794 | 0% | 17% | $62,778,144 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.2% | 2,501,286 | 0% | 0% | $56,529,064 |
| DIMENSIONAL FUND ADVISORS LP | 5.1% | 2,060,597 | +5.7% | 0.01% | $46,572,366 |
| D. E. Shaw & Co., Inc. | 4.9% | 1,982,724 | -2.8% | 0.04% | $44,809,563 |
| STATE STREET CORP | 4.7% | 1,919,610 | +1.9% | 0% | $43,383,186 |
| RENAISSANCE TECHNOLOGIES LLC | 4.5% | 1,825,501 | -3.1% | 0.06% | $41,256,323 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 1,784,049 | 0% | 0% | $40,319,507 |
| GOLDMAN SACHS GROUP INC | 3.9% | 1,569,916 | +21% | 0% | $35,480,101 |
| MORGAN STANLEY | 3.4% | 1,392,547 | +17% | 0% | $31,471,582 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.8% | 1,143,820 | -2.2% | 0% | $25,855,369 |
| AMERICAN CENTURY COMPANIES INC | 2.1% | 837,563 | -37% | 0.01% | $18,928,924 |
| CITADEL ADVISORS LLC | 2% | 797,281 | -2.7% | 0.01% | $18,018,550 |
| Impax Asset Management Group plc | 1.9% | 750,027 | 0% | 0.12% | $16,950,610 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.8% | 732,042 | +8.2% | 0% | $16,544,149 |
| GAGNON SECURITIES LLC | 1.5% | 617,510 | +23% | 3.2% | $13,955,726 |
| UBS Group AG | 1.4% | 562,040 | +0.61% | 0% | $12,702,104 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 526,851 | +17% | 0.01% | $11,906,833 |
| NORTHERN TRUST CORP | 1.3% | 519,412 | -1.7% | 0% | $11,738,711 |
| LSV ASSET MANAGEMENT | 1.3% | 517,100 | +62% | 0.03% | $11,686,000 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.2% | 478,383 | -7.7% | 0% | $10,811,456 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1% | 411,373 | -6.8% | 0.19% | $9,297,030 |
| Bridge City Capital, LLC | 0.99% | 402,765 | +41% | 2.5% | $9,102,489 |
| DEUTSCHE BANK AG\ | 0.97% | 391,677 | +1.1% | 0% | $8,851,901 |
| Gagnon Advisors, LLC | 0.87% | 352,637 | +35% | 5.9% | $7,969,596 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q1 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 403,265 | $10,230,833 | +$6,181,478 | $25.37 | 8 |
| 2026 Q1 | 43,579,743 | $985,375,457 | -$75,505,778 | $22.60 | 240 |
| 2025 Q4 | 46,958,449 | $1,215,271,808 | -$25,755,928 | $25.88 | 261 |
| 2025 Q3 | 47,959,507 | $1,235,859,061 | -$66,264,911 | $25.77 | 236 |
| 2025 Q2 | 50,544,394 | $1,207,981,451 | -$359,554 | $23.90 | 230 |
| 2025 Q1 | 50,618,298 | $1,257,877,040 | +$32,555,405 | $24.85 | 234 |
| 2024 Q4 | 49,919,979 | $940,563,254 | -$16,965,371 | $18.84 | 229 |
| 2024 Q3 | 51,260,756 | $771,636,682 | -$165,775,978 | $15.05 | 235 |
| 2024 Q2 | 51,907,448 | $1,485,006,047 | +$74,680,393 | $28.61 | 274 |
| 2024 Q1 | 49,148,207 | $1,436,043,998 | +$18,739,360 | $29.22 | 267 |
| 2023 Q4 | 48,345,728 | $1,631,093,080 | -$9,894,207 | $33.74 | 257 |
| 2023 Q3 | 47,455,861 | $1,455,850,736 | -$4,481,511 | $30.68 | 257 |
| 2023 Q2 | 46,990,206 | $1,882,388,532 | +$21,451,347 | $40.07 | 253 |
| 2023 Q1 | 46,385,914 | $1,892,433,173 | -$75,486,559 | $40.81 | 265 |
| 2022 Q4 | 48,634,371 | $1,878,207,869 | -$89,054,242 | $38.61 | 268 |
| 2022 Q3 | 50,521,839 | $2,687,327,030 | +$59,266,186 | $53.19 | 258 |
| 2022 Q2 | 48,969,306 | $2,854,741,313 | -$35,627,879 | $58.30 | 271 |
| 2022 Q1 | 49,630,099 | $3,785,465,240 | -$42,659,805 | $76.32 | 288 |
| 2021 Q4 | 50,609,311 | $3,045,397,753 | +$82,990,546 | $60.17 | 264 |
| 2021 Q3 | 49,136,451 | $2,751,568,452 | -$7,655,613 | $56.00 | 252 |
| 2021 Q2 | 49,208,257 | $2,985,423,936 | -$36,503,493 | $60.68 | 254 |
| 2021 Q1 | 49,838,933 | $3,492,801,331 | -$28,991,250 | $70.09 | 265 |
| 2020 Q4 | 50,361,027 | $3,013,925,217 | +$130,605,627 | $59.84 | 257 |
| 2020 Q3 | 48,261,472 | $2,900,663,579 | -$13,442,917 | $60.12 | 255 |
| 2020 Q2 | 48,714,511 | $2,556,091,692 | +$106,862,036 | $52.47 | 241 |